# The CLARA Study From the Acute Leukemia French Association (ALFA 0702 Trial)

> **NCT00932412** · PHASE2 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 735 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** CLARA
- **DRUG:** HDAc

## Key facts

- **NCT ID:** NCT00932412
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 735 (ACTUAL)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00932412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00932412, "The CLARA Study From the Acute Leukemia French Association (ALFA 0702 Trial)". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00932412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*